In its first major deal, Dicerna Pharmaceuticals Inc. is partnering with Japanese biopharmaceutical firm Kyowa Hakko Kirin Co. Ltd. to discover, develop and commercialize drug delivery systems and siRNA medications using Dicerna's Dicer Substrate Technology for undisclosed oncology targets. (BioWorld Today) Read More
